Frederick A. Schroeder
Horizon Therapeutics (United States)(US)
Publications by Year
Research Areas
Histone Deacetylase Inhibitors Research, Epigenetics and DNA Methylation, Protein Degradation and Inhibitors, Genetics and Neurodevelopmental Disorders, Neuroscience and Neuropharmacology Research
Most-Cited Works
- → Antidepressant-Like Effects of the Histone Deacetylase Inhibitor, Sodium Butyrate, in the Mouse(2006)530 cited
- → Dopamine D2‐like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP‐protein kinase A and NMDA receptor signaling(2004)150 cited
- → Copy Number Variation in Obsessive-Compulsive Disorder and Tourette Syndrome: A Cross-Disorder Study(2014)139 cited
- → A Selective HDAC 1/2 Inhibitor Modulates Chromatin and Gene Expression in Brain and Alters Mouse Behavior in Two Mood-Related Tests(2013)138 cited
- → Drug-Induced Activation of Dopamine D1 Receptor Signaling and Inhibition of Class I/II Histone Deacetylase Induce Chromatin Remodeling in Reward Circuitry and Modulate Cocaine-Related Behaviors(2008)137 cited
- → Setdb1 Histone Methyltransferase Regulates Mood-Related Behaviors and Expression of the NMDA Receptor Subunit NR2B(2010)114 cited
- → In Vivo Imaging of Histone Deacetylases (HDACs) in the Central Nervous System and Major Peripheral Organs(2014)105 cited
- → HDAC6 Brain Mapping with [18F]Bavarostat Enabled by a Ru-Mediated Deoxyfluorination(2017)80 cited
- → PET neuroimaging reveals histone deacetylase dysregulation in schizophrenia(2018)76 cited
- → Imaging Evaluation of 5HT2C Agonists, [11C]WAY-163909 and [11C]Vabicaserin, Formed by Pictet–Spengler Cyclization(2014)68 cited